ASPIRE: Treating Children With Atopic Dermatitis (Eczema)Research Question:
How do topical medications for atopic dermatitis affect health and quality of life
in children and their caregivers?
Basic Study Information
Purpose:Location: University of Rochester Dermatology
This study will monitor the effects of ointments, crisaborole and tacrolimus 0.03%,
on patient-reported outcomes (PROs) and caregiver burden in children (ages 5 to 15
years) with atopic dermatitis over a 12 week period of time. The goal of this study
is to detect changes in PROs and caregiver burden during treatment for atopic dermatitis
of moderate or less severity. The study design will allow us to correlate PROs and
caregiver burden with treatment response and disease improvement in children.
Study Reference #: 00073062
Lead Researcher (Principal Investigator)
Lead Researcher: Julie Wolf
Study Contact InformationStudy Coordinator: Alicia Papilia
Phone: (585) 273-4195
Additional Study Details
This is an open-label, randomized, cross-sectional study to monitor the effects of
crisaborole and tacrolimus 0.03% on patient-reported outcomes (PROs) and caregiver
burden in children (ages 5 to 15 years, inclusive) with mild to moderate atopic dermatitis
over a 12 week period of time. The goal of this study is to detect changes in PROs
and caregiver burden during treatment for atopic dermatitis of moderate or less severity.
The study design will allow us to correlate PROs and caregiver burden with treatment
response and disease improvement in children.
Children with mild to moderate atopic dermatitis (ages 5 to 15 years, inclusive) are
eligible. Their parent or caregiver must also participate in the study with the child
participant. The child will be randomized to tacrolimus 0.03% or crisaborole for their
atopic dermatitis which they will use for 12 weeks. The study consists of 3 clinic
visits over 12 weeks (baseline, 6 weeks, 12 weeks) during which the child's atopics
dermatitis will be clinically assessed and the child and caregiver/parent will complete
a questionnaire on an iPad. Subjects will be reimbursed for their participation in
Number of Visits:
2 to 5
Child participants will receive a $10 gift card at the end of each study visit for
their participation. All adult caregiver subjects will be reimbursed $100 for completion
of all study procedures. Payment will be prorated based on number of assessments completed
in the study. Subjects will be paid $20 for completion of Baseline Assessment, $40
for completion of 6 Week Assessment, and $40 for completion of 12 Week Assessment.
A check will be issued to the adult caregiver (i.e., caregiver) after completion of
12 Week Assessment or whenever their participation in the study has ended.
Learn More About These Conditions
More information about Dermatitis, Atopic
Trial Not Found
The study you are looking for is not active at this time.
Return to Search